References
- Henderson. Acute leukemia general consideration. Hematology fourth edition. McGraw-Hill publishing company, New York 1990; 236–250
- Schiffer C. A., Wade J. D. Supportive care: issues in the use of blood products and treatment of infection. Seminars Oncology 1987; 14: 454–460
- Pamphillon D. H. Application of ultraviolet light in the preparation of platelet concentrates. Transfusion 1989; 29: 379–384
- Junghans R. P. High dose intravenous gammaglobulin to suppress alloimmune destruction of donor platelets. American Journal Medicine 1984; 76: 204–210
- Lee E., Schiffer C. A. Intravenous immunoglobulin for patients alloimmunized to random donor platelet transfusion. Transfusion 1987; 27: 245–248
- Cajozzo A., Citarrella P. Disseminated intravascular coagulation. Advances in Haemostasis and Thrombosis. Plenum Press, New York 1985; 303–314
- Bick R. L. Disorders of hemostasis and thrombosis. Principles and clinical practice. Thieme Inc., New York 1985
- Rodeghiero F., Barbui T. Two dimensional Immunoelectrophoresis of ATIII during DIC in Acute Leukemia. Thrombosis Research 1977; 12: 191–198
- Perricone R., Cajozzo A. The treatment of disseminated intravascular coagulation in Acute Leukemia using ATIII. Advances in Vascular Pathology, A. Strano, S. Novo, 1990; 693–699
- Wijermans P. W., et al. Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: Reversal of the bleeding disorder by cell differentiation. Blood 1989; 73: 800–805
- Vinazer H. Clinical use of ATIII concentrates. Vox Sang 1987; 53: 193–198